Navigation Links
US Drug Watchdog Now Urges Women Who Had A Out Of The Blue Heart Attack Or Stroke Who Were Also Using Yaz or Yasmin Birth Control Pills To Call The Johnson Law Group ASAP
Date:1/17/2013

(PRWEB) January 17, 2013

The US Drug Watchdog says, “We are urging close friends, family members, or mothers of younger women who had an out the blue heart attack, a stroke, a pulmonary embolism, developed a blood clot or other severe medical complications to contact the Johnson Law Group immediately, if the victim was also using the birth control pills called Yaz, Yasmin, or generic version Ocella." As a background, in September of 2009, the US FDA released a warning letter sent to Bayer Pharmaceuticals over Yaz & Yasmin. The letter indicates that the drug maker hid out-of-specification test results for key ingredients in the birth control pills. The US Drug Watchdog says, "If you, a friend, or a loved one was using birth control pills called Yaz, Yasmin, or their generic version Ocella, and severe side effects occurred, such a pulmonary embolism, a heart attack, a stroke, or other severe medical conditions please contact The Johnson Law Group immediately at 1-800-996-9900. http://www.johnsonlawgroup.com/

Possible Side Effects Yaz/Yasmin Birth Control Pills

  • Yaz / Yasmin Stroke or Heart attack
  • Yaz / Yasmin Pulmonary Embolism
  • Yaz / Yasmin Deep Vein Thrombosis
  • Yaz / Yasmin Blood Clots
  • Sudden Death from Yaz or Yasmin

The US Drug Watchdog says, "One of the biggest problems we have with respect to our drug initiative work, is the average US consumer never hears about a drug recall, or serious side effects related to a specific drug's use. We are attempting to change this very sad fact with aggressive initiatives focused on increasing public awareness, and suggesting possible help for victims. In the instances of the birth control pills called Yaz. Yasmin, or their generic version Ocella we doubt a young woman would ever connect the dots between a out of the blue heart attack, or a stroke, and the use of these birth control pills." http://USDrugWatchdog.Com

MDL No. 2100 (3:09-md-02100-DRH-PMF)

Read the full story at http://www.prweb.com/releases/2013/1/prweb10313947.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. US Drug Watchdog Now Offers Victims Of A Transvaginal Mesh Product Failure The Names Of The Best Possible Women Lawyers To Help Natiowide
2. US Drug Watchdog Now Offers Metal on Metal Hip Implant Recipients With Elevated Metal Levels the Names of the Best Attorneys-Get Compensated
3. US Drug Watchdog Now Urges Loved Ones Of Diabetics Diagnosed with Bladder Cancer To Call The Johnson Law Group If The Loved One Also Used the Diabetes Drug Called Actos
4. US Drug Watchdog Now Urges Transvaginal Mesh Product Failure Victims To Call Them For The Names Of The Best Women Attorneys To Help Them With A Staggering Dilemma
5. US Drug Watchdog Now Offers To Help All DePuy Pinnacle All Metal Hip Implant Recipients get to the Best Law Firms If A Blood Test Reveals Elevated Metal Levels
6. US Drug Watchdog Now Urges Victims of a Transvaginal Mesh Product Failure To Get Some Meaningful Help From Women Attorneys Who Understand This Horrific Mess and the Costs
7. US Drug Watchdog Now Urges All 500,000 US Recipients Of A Metal on Metal Hip Implant To Get A Blood Test for Elevated Levels Of Cobalt and Chromium
8. US Drug Watchdog Now Urges Victims of a Unsuccessful Transvaginal Mesh Product Revision Surgery to Call Them for the Names of the Best Possible Lawyers - Who Are All Women
9. US Drug Watchdog Now Puts a New Emphasis on DePuy Pinnacle Hip Implant Recipients and They Urge Them to Get a Blood Test for Elevated Metals Levels
10. US Drug Watchdog Now Urges Families Of Diabetics Diagnosed with Bladder Cancer To Call The Johnson Law Group If They Used the Diabetes Drug Called Actos
11. US Drug Watchdog Is Now Open All Weekends To Help Victims Of A Transvaginal Mesh Product Failures With A Service That Includes Naming Top Attorneys--Who Are All Women
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... “The Journey: From the Mountains to the Mission ... lost souls in the Philippines. “The Journey: From the Mountains to the Mission Field” ... the Bible. She has taught all ages and currently teaches a class of ladies ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent and ... apnea using cutting-edge Oventus O2Vent technology. As many as 18 million Americans ... frequent cessation in breathing. Oral appliances can offer significant relief to about 75 ...
(Date:10/12/2017)... ... October 12, 2017 , ... IsoComforter, Inc. ( https://isocomforter.com ... introduction of an innovative new design of the shoulder pad. The shoulder pad ... comfort while controlling your pain while using cold therapy. By utilizing ice and water ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... system that we intend to develop to enable prevention of a major side ... severe hearing loss, especially in pediatric patients. For cisplatin, hearing loss is FDA ...
(Date:10/12/2017)... ... 12, 2017 , ... Leading pediatric oncology experts at Children’s National Health ... Congress of the International Society of Paediatric Oncology (SIOP) Oct. 12-15. Chaired ... Cancer and Blood Disorders at Children’s National, and Stephen P. Hunger, M.D., Chief ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... MIAMI , Sept. 27, 2017  Commended for their ... recent notable awards. Ranked as number one in the South ... ninth time in Inc. 5000 yearly list, the national specialty ... CEO, Armando Bardisa will soon be honored by ... Set to receive his award ...
(Date:9/25/2017)... , Sept. 25, 2017   Montrium , ... File solutions, today—from the IQPC Trial Master Files ... , NL)—announced that EastHORN Clinical Services has selected ... programs and TMF management. EastHORN, a leading European ... platform to increase transparency to enable greater collaboration ...
(Date:9/23/2017)... HORSHAM, Pa. , Sept. 22, 2017 ... received a complete response letter from the U.S. Food ... (BLA) seeking approval of sirukumab for the treatment of ... response letter indicates additional clinical data are needed to ... of moderately to severely active RA. ...
Breaking Medicine Technology: